Healthcare - Biotechnology - NASDAQ - NL
$ 1.57
-5.42 %
$ 41.3 M
Market Cap
-1.76
P/E
Price Target
Average
282.17%
Revenue Forecast
Estimate
36.95%
EBIT
Estimate
24.19%
Net Income
Estimate
3.99%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
LAVA Therapeutics N.V.
Wall Street analysts predict an average 1-year price target for LVTX of $6 , with forecasts ranging from a low of $6 to a high of $6 .
LVTX Lowest Price Target
Wall Street Target
6 USD
282.17%
LVTX Average Price Target
Wall Street Target
6 USD
282.17%
LVTX Highest Price Target
Wall Street Target
6 USD
282.17%
REVENUE FORECAST
Revenue Forecast Chart LVTX
EBIT FORECAST
EBIT Forecast Chart LVTX
NET INCOME FORECAST
Net Income Chart LVTX